Latest filing published 27 Feb 2026 for Pandox Aktiebolag, €28k.
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
This profile gathers the share dealings of Martin Creydt in Pandox Aktiebolag, where the filings describe the role as board member. In total, 9 filings cover trades dated from 10 March 2017 to 27 February 2026.
The open-market side counts 7 purchases for €209k alongside 2 sales for €93k. The net balance comes to €116k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2026: 1 purchase and no sales on the market.
Half of the purchases are above €28k and half below. 5 out of 7 purchases came within 30 days of a purchase by at least one other insider of the same company. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
The record was last updated on 27 February 2026 with an open-market purchase (€28k) in Pandox Aktiebolag. The median gap between trade and publication is zero days: most filings appear on the same day. The legal deadline for notifying a trade is three business days (MAR article 19). Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration